{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:52:00Z","timestamp":1792036320750,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PA 1529\/2-1"],"award-info":[{"award-number":["PA 1529\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["\/NIEHS R01 ES016931"],"award-info":[{"award-number":["\/NIEHS R01 ES016931"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP20101"],"award-info":[{"award-number":["GGP20101"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015672","name":"European Huntington's Disease Network","doi-asserted-by":"publisher","award":["903"],"award-info":[{"award-number":["903"]}],"id":[{"id":"10.13039\/100015672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ymthe.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:11:19Z","timestamp":1663330279000},"page":"282-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington\u2019s disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Giuseppe","family":"Pepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Capocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Realini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiuscia","family":"Martinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana Francesca","family":"Bovier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Jo","family":"Bichell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Scarselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Di Cicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena A.","family":"Digilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fucile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Parlato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Di Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6906-7372","authenticated-orcid":false,"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.09.004_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2022.09.004_bib3","doi-asserted-by":"crossref","first-page":"101358","DOI":"10.1016\/j.arr.2021.101358","article-title":"Systemic manifestation and contribution of peripheral tissues to Huntington\u2019s disease pathogenesis","volume":"69","author":"Chuang","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ymthe.2022.09.004_bib4","doi-asserted-by":"crossref","first-page":"104963","DOI":"10.1016\/j.nbd.2020.104963","article-title":"The contribution of glial cells to Huntington\u2019s disease pathogenesis","volume":"143","author":"Wilton","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2022.09.004_bib5","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbadis.2017.02.013","article-title":"Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington\u2019s disease mouse model","volume":"1863","author":"Bichell","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ymthe.2022.09.004_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1073\/pnas.1717877115","article-title":"Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington\u2019s disease","volume":"115","author":"Sbodio","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.09.004_bib7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s11011-021-00844-y","article-title":"Metabolism in Huntington\u2019s disease: a major contributor to pathology","volume":"37","author":"Singh","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymthe.2022.09.004_bib8","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1","volume":"30","author":"Maglione","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fnins.2016.00457","article-title":"Impaired levels of gangliosides in the corpus callosum of Huntington disease animal models","volume":"10","author":"Di Pardo","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1471-4159.2010.06964.x","article-title":"Cerebellar lipid differences between R6\/1 transgenic mice and humans with Huntington\u2019s disease","volume":"115","author":"Denny","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2022.09.004_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","article-title":"Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease","volume":"27","author":"Desplats","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2022.09.004_bib12","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/jnc.15325","article-title":"An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington\u2019s disease caudate nucleus","volume":"157","author":"Hunter","year":"2021","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2022.09.004_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tips.2018.02.009","article-title":"The S1P Axis: new exciting route for treating Huntington\u2019s disease","volume":"39","author":"Di Pardo","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib14","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/hmg\/ddy153","article-title":"Stimulation of S1PR 5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington\u2019s disease","volume":"27","author":"Di Pardo","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.09.004_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnmol.2019.00100","article-title":"Stimulation of sphingosine kinase 1 (SPHK1) is beneficial in a Huntington\u2019s disease pre-clinical model","volume":"12","author":"Di Pardo","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/hmg\/ddx046","article-title":"Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease","volume":"26","author":"Moruno-Manchon","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.09.004_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41467-017-00353-6","article-title":"Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements","volume":"8","author":"Pirhaji","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.09.004_bib18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fnins.2017.00698","article-title":"De novo synthesis of sphingolipids is defective in experimental models of Huntington\u2019s disease","volume":"11","author":"Di Pardo","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib19","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/s41598-017-05709-y","article-title":"Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington\u2019s disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.09.004_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nmeth.3940","article-title":"Revealing disease-associated pathways by network integration of untargeted metabolomics","volume":"13","author":"Pirhaji","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2022.09.004_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fphar.2019.00807","article-title":"Sphingosine 1-phosphate receptors and metabolic enzymes as druggable targets for brain diseases","volume":"10","author":"Grassi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib22","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.3390\/ijms22147353","article-title":"Novelty of sphingolipids in the central nervous system physiology and disease: focusing on the sphingolipid hypothesis of neuroinflammation and neurodegeneration","volume":"22","author":"Ayub","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000362991","article-title":"Sphingosine-1-phosphate: boon and bane for the brain","volume":"34","author":"Van Echten-Deckert","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ymthe.2022.09.004_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.advenzreg.2009.10.024","article-title":"Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function","volume":"50","author":"Serra","year":"2010","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.ymthe.2022.09.004_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-030-50621-6_6","article-title":"Druggable sphingolipid pathways: experimental models and clinical opportunities","volume":"1274","author":"Blaho","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib27","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/cdd.2011.7","article-title":"Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism","volume":"18","author":"Hagen","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2022.09.004_bib28","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1074\/jbc.M807336200","article-title":"Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons","volume":"284","author":"Hagen","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.09.004_bib29","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3390\/cells9102189","article-title":"Neurodegeneration caused by S1P-lyase deficiency involves calcium-dependent tau pathology and abnormal histone acetylation","volume":"9","author":"Alam","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2022.09.004_bib30","doi-asserted-by":"crossref","first-page":"37064","DOI":"10.1038\/srep37064","article-title":"Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin- proteasome mediated mechanism","volume":"6","author":"Mitroi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.09.004_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/15548627.2017.1291471","article-title":"SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production","volume":"13","author":"Mitroi","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2022.09.004_bib32","doi-asserted-by":"crossref","first-page":"e59630","DOI":"10.1371\/journal.pone.0059630","article-title":"Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis","volume":"8","author":"Billich","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.09.004_bib33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.fct.2017.12.004","article-title":"Caramel color safety - an update","volume":"111","author":"Vollmuth","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib34","doi-asserted-by":"crossref","first-page":"15213","DOI":"10.1038\/srep15213","article-title":"Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy","volume":"5","author":"Moruno Manchon","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.09.004_bib35","first-page":"41","article-title":"Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy","volume":"7","author":"Nguyen-Tran","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2022.09.004_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2249.1991.tb05729.x","article-title":"Immunosuppressive effects of 2-acetyl-4-tetrahydroxybutyl imidazole (THI) in the rat","volume":"85","author":"Gobin","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib37","doi-asserted-by":"crossref","first-page":"e4770","DOI":"10.1371\/journal.pone.0004770","article-title":"Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice","volume":"4","author":"Matamales","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.09.004_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington\u2019s disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2022.09.004_bib39","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/hbm.22391","article-title":"MRI measures of corpus callosum iron and myelin in early Huntington\u2019s disease","volume":"35","author":"Di Paola","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ymthe.2022.09.004_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2021.02.006","article-title":"Evaluation of early microstructural changes in the R6\/1 mouse model of Huntington\u2019s disease by ultra-high field diffusion MR imaging","volume":"102","author":"Gatto","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2022.09.004_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jnnp-2020-324377","article-title":"Diffusion imaging in Huntington\u2019s disease: comprehensive review","volume":"92","author":"Estevez-Fraga","year":"2020","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2022.09.004_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/hbm.21205","article-title":"Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington\u2019s disease","volume":"33","author":"Dumas","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ymthe.2022.09.004_bib43","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.09.004_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn1517","article-title":"PDZ domain proteins of synapses","volume":"5","author":"Kim","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib45","doi-asserted-by":"crossref","first-page":"E4736","DOI":"10.1073\/pnas.1609702113","article-title":"PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61","volume":"113","author":"Won","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.09.004_bib46","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1093\/hmg\/ddg271","article-title":"Fly models of Huntington\u2019s disease","volume":"12","author":"Marsh","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.09.004_bib47","doi-asserted-by":"crossref","first-page":"74311","DOI":"10.3390\/ijms21197431","article-title":"The discovery of highly potent THP derivatives as OCTN2 inhibitors: from structure-based virtual screening to in\u00a0vivo biological activity","volume":"21","author":"Di Cristo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib48","doi-asserted-by":"crossref","first-page":"103526","DOI":"10.1016\/j.mcn.2020.103526","article-title":"Pharmacological inhibition of sphingosine-1-phosphate lyase partially reverses spatial memory impairment in streptozotocin-diabetic rats","volume":"107","author":"Baranowska","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lfs.2013.07.017","article-title":"Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest","volume":"93","author":"Gorshkova","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/00498251003611376","article-title":"Pharmacokinetic\/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate","volume":"40","author":"Yu","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ymthe.2022.09.004_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature06097","article-title":"Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide","volume":"449","author":"D\u2019Angelo","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.09.004_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgme.2016.11.390","article-title":"The metabolism of glucocerebrosides - from 1965 to the present","volume":"120","author":"Futerman","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2022.09.004_bib54","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.bbamem.2006.08.004","article-title":"Intracellular trafficking of sphingolipids: relationship to biosynthesis","volume":"1758","author":"Futerman","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2022.09.004_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev.biophys.093008.131357","article-title":"Lipids and cholesterol as regulators of traffic in the endomembrane system","volume":"39","author":"Lippincott-Schwartz","year":"2010","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.ymthe.2022.09.004_bib56","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1152\/physrev.2001.81.4.1689","article-title":"The organizing potential of sphingolipids in intracellular membrane transport","volume":"81","author":"Holthuis","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2022.09.004_bib57","doi-asserted-by":"crossref","first-page":"e0162977","DOI":"10.1371\/journal.pone.0162977","article-title":"Up-regulated expression of LAMP2 and autophagy activity during neuroendocrine differentiation of prostate cancer LNCaP cells","volume":"11","author":"Morell","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.09.004_bib58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnagi.2019.00049","article-title":"Influence of normal aging on brain autophagy: a complex scenario","volume":"11","author":"Loeffler","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib60","doi-asserted-by":"crossref","first-page":"769184","DOI":"10.3389\/fmolb.2021.769184","article-title":"Molecular strategies to target protein aggregation in Huntington\u2019s disease","volume":"8","author":"Jarosi\u0144ska","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","article-title":"Genetics and neuropathology of Huntington\u2019s disease","volume":"98","author":"Reiner","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib62","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington\u2019s disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5607\/en.2014.23.1.36","article-title":"Therapeutic approaches for inhibition of protein aggregation in Huntington\u2019s disease","volume":"23","author":"Kim","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib64","doi-asserted-by":"crossref","first-page":"e17056","DOI":"10.7554\/eLife.17056","article-title":"Real-time imaging of Huntingtin aggregates diverting target search and gene transcription","volume":"5","author":"Li","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2022.09.004_bib65","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jmg.36.10.739","article-title":"A molecular investigation of true dominance in Huntington\u2019s disease","volume":"36","author":"Narain","year":"1999","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2022.09.004_bib66","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.09.004_bib67","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1038\/s41467-021-26684-z","article-title":"Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties","volume":"12","author":"Riguet","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.09.004_bib68","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.09.004_bib69","doi-asserted-by":"crossref","first-page":"22137","DOI":"10.1038\/s41598-020-78790-5","article-title":"Analysis of mutant and total huntingtin expression in Huntington\u2019s disease murine models","volume":"10","author":"Fodale","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.09.004_bib70","doi-asserted-by":"crossref","first-page":"e0189891","DOI":"10.1371\/journal.pone.0189891","article-title":"Quantification of huntingtin protein species in Huntington\u2019s disease patient leukocytes using optimised electrochemiluminescence immunoassays","volume":"12","author":"Hensman Moss","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.09.004_bib71","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/hyb.2005.24.231","article-title":"Epitope mapping of monoclonal antibody 4C8 recognizing the protein huntingtin","volume":"24","author":"Cong","year":"2005","journal-title":"Hybridoma"},{"key":"10.1016\/j.ymthe.2022.09.004_bib72","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbalip.2014.02.005","article-title":"Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen","volume":"1841","author":"Guo","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2022.09.004_bib73","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/1440-1681.13124","article-title":"SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway","volume":"46","author":"Gu","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCRESAHA.120.318412","article-title":"Programming to S1PR1+ endothelial cells promotes restoration of vascular integrity","volume":"129","author":"Akhter","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2022.09.004_bib75","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/biomedicines9091121","article-title":"Spns2 transporter contributes to the accumulation of S1P in cystic fibrosis human bronchial epithelial cells","volume":"9","author":"Zulueta","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2022.09.004_bib76","doi-asserted-by":"crossref","first-page":"105009","DOI":"10.1016\/j.nbd.2020.105009","article-title":"Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington's disease","volume":"143","author":"Di Pardo","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2022.09.004_bib77","doi-asserted-by":"crossref","first-page":"E3304","DOI":"10.3390\/ijms20133304","article-title":"The link between gaucher disease and Parkinson\u2019s disease sheds light on old and novel disorders of sphingolipid metabolism","volume":"20","author":"Indellicato","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2022.09.004_bib78","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2020.10.008","article-title":"Sphingolipids metabolism alteration in the central nervous system: amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases","volume":"112","author":"Bouscary","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-019-0336-2","article-title":"Glucocerebrosidase and its relevance to Parkinson disease","volume":"14","author":"Do","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2022.09.004_bib80","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1093\/hmg\/ddv439","article-title":"Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase","volume":"24","author":"Henriques","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2022.09.004_bib81","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1073\/pnas.1508767112","article-title":"Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis","volume":"112","author":"Dodge","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.09.004_bib82","doi-asserted-by":"crossref","first-page":"e12836","DOI":"10.15252\/emmm.202012836","article-title":"The rapidly evolving view of lysosomal storage diseases","volume":"13","author":"Parenti","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2022.09.004_bib83","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1194\/jlr.M073510","article-title":"Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal \u03b2-glucocerebrosidase","volume":"58","author":"Abdul-Hammed","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ymthe.2022.09.004_bib84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymthe.2022.09.004_bib85","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jnc.14853","article-title":"The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington\u2019s disease","volume":"151","author":"Wanker","year":"2019","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2022.09.004_bib86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases","volume":"113","author":"O\u2019Sullivan","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymthe.2022.09.004_bib87","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.phrs.2016.09.025","article-title":"To fingolimod and beyond: the rich pipeline of drug candidates that target S1P signaling","volume":"113","author":"Chew","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymthe.2022.09.004_bib88","doi-asserted-by":"crossref","first-page":"108005","DOI":"10.1016\/j.pharmthera.2021.108005","article-title":"Compartmentalization of Sphingolipid metabolism: implications for signaling and therapy","volume":"232","author":"Canals","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2022.09.004_bib89","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/jrpp.jrpp_33_24","article-title":"The clinical efficacy of imiglucerase versus eliglustat in patients with gaucher\u2019s disease type 1: a systematic review","volume":"7","author":"Nabizadeh","year":"2018","journal-title":"J.\u00a0Res. Pharm. Pract."},{"key":"10.1016\/j.ymthe.2022.09.004_bib90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.09.004_bib91","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.09.004_bib92","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ecoenv.2018.07.020","article-title":"Effects of the synthetic estrogen 17-\u03b1-ethinylestradiol on Drosophila melanogaster: dose and gender dependence","volume":"162","author":"Bovier","year":"2018","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ymthe.2022.09.004_bib93","first-page":"e59535","article-title":"Methods to test endocrine disruption in Drosophila melanogaster","author":"Bovier","year":"2019","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2022.09.004_bib94","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1007\/s00216-015-8585-6","article-title":"Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS\/MS","volume":"407","author":"Basit","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ymthe.2022.09.004_bib95","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1756-6606-6-55","article-title":"Changes of peripheral TGF-\u03b21 depend on monocytes-derived macrophages in Huntington disease","volume":"6","author":"Di Pardo","year":"2013","journal-title":"Mol. Brain"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622005585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622005585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:06:13Z","timestamp":1778616373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622005585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1525001622005585"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}